SI Appendix Methods

In vivo mouse model (Part I)
Male C57BL/6J mice (12 weeks old) were obtained from Janvier Labs (https://www.janvier-labs.com, France) and housed under temperature and humidity-controlled environment with free access to standard rodent chow (R34, 4% fat, Lantmannen, Sweden) and tap water. After 10 days of acclimatization baseline metabolic and cardiovascular functions were obtained (described below), and once completed, the mice were fed with HFD (60 kcal% fat, 20 kcal% carbohydrate, 20 kcal% protein, D12492, Research Diets Inc., New Brunswick, NJ) for 7 weeks, with or without simultaneous supplementation with inorganic nitrate in the drinking water (NaNO3, 1.0 mmol/kg/day). In order to inhibit endogenous NOS the mice were treated with L-NAME (1 g/L drinking water). The purpose of NOS inhibition was twofold. First, we wanted to add hypertension to the model to better resemble a metabolic syndrome. Second, we wanted to exclude that any effects of nitrate/nitrite were mediated by NOS as has suggested by others (1-3).
Additionally, a subset of mice (n=24) fed with standard chow or HFD were used to study the effects of nitrate in the absence of L-NAME in the drinking water. All animals received food and water ad libitum. Food and water intake and body weight were monitored throughout the study period. After 5 and 6 weeks, an intraperitoneal glucose tolerance test and an intraperitoneal insulin tolerance test were performed respectively and blood pressure was recorded. These procedures are explained below. After 7 weeks of treatment, the animals were euthanized and tissues of interest collected (see below).
In separate series of experiments, we used germ-free mice (n=17) that received irradiated HFD (40 kcal% fat, 43 kcal% carbohydrate, 17 kcal% protein, D12079B, Research Diets Inc., New Brunswick, NJ) and L-NAME (1 g/L drinking water) for 7 weeks. At the end of this period the mice were euthanized and the livers were removed for further analyses. The germ-free status of the animals was tested and confirmed weekly by anaerobic and aerobic culturing of fecal samples.
Blood pressure: Blood pressure was measured using the Coda High Throughput Noninvasive Tail Monitoring System (Kent Scientific, Torrington, CT, USA), following the manufacturer's protocol. After a training period, measurements of systolic, diastolic and mean arterial blood pressure (MAP) were repeated daily for 3 days, and averaged blood pressure data from each mouse was used for analysis.
Food intake and body composition analysis:
Food intake was assessed on a weekly basis and dual-emission x-ray absorptiometry (DEXA) studies were performed using a Lunar PIXImus densitometer (GE Medical-Lunar, Madison, WI, USA) in isofluraneanaesthetized (Forene; Abbott Scandinavia AB, Solna, Sweden) animals to determine fat and lean masses, as previously described (4, 5) .
Glucose tolerance test:
Intraperitoneal glucose tolerance tests (IPGTT) were performed at approximately 1 PM following 5 hours of fasting. Mice received 30% Dglucose (2 g/kg body weight) intraperitoneally, and blood samples were obtained from the tail vein before the glucose load (t=0) and at 15, 30, 60 and 120 min after glucose administration. A portable glucose meter (FreeStyle Lite; Abbott Diabetes Care Inc) was used to measure blood glucose levels.
Insulin tolerance tests:
Intraperitoneal insulin tolerance tests (IPITT) were performed similarly to IPGTT, during the same period of the day, but without previous fasting. A bolus of insulin (0.75 IU/kg body weight; Novorapid 100 IU/ml, Novo Nordisk A/S, Bagsvaerd, Denmark) was injected (0.2 IU/ml in saline) and repeated blood samples from the tail vein were obtained for glucose measurements.
Animal euthanasia and sample harvest: Mice were anesthetized with isoflurane and blood samples were collected through inferior vena cava. Whole blood with 0.5 mmol EDTA (Sigma-Aldrich, Stockholm, Sweden) was centrifuged immediately at 4 °C for 5 min (6000 g), and plasma was collected and stored at -80 °C for later analyses. The organs were collected and snap frozen while fresh mesenteric artery was collected for wire myography (described below).
Vascular reactivity: Third branches of mesenteric arteries were isolated and arterial rings (2 mm) were mounted in myograph chambers (model 620M, Danish Myo Technology, Aarhus, Denmark) in oxygenated Krebs solution, as described in detail previously (6, 7) . Resting tension was set according to a normalization procedure, and vessel viability was assessed by the responses to 0.1 mol/L KCl. After preconstriction with norepinephrine (NE, 3x10 -6 mol/L), the acetylcholine (ACh, 10 -9 -10 -4 mol/L) vascular response was evaluated as an index of endothelial function.
Nitrate-nitrite measurement: Nitrite and nitrate were analyzed by HPLC (ENO-20) as described previously (8, 9) . Plasma samples (10 μl) were injected using a Hamilton syringe, and nitrite and nitrate were separated by reverse phase/ion exchange chromatography followed by nitrate reduction to nitrite by cadmium and reduced copper. Nitrite was then derivatized using Griess reagent to form diazo compounds and analyzed by detection at 540 nm.
HepG2 cells (Part II)
Human HepG2 cells were grown in DMEM medium (5.5 mM glucose) supplemented with 10% fetal bovine serum and penicillin and streptomycin (50 mg/L). Cells were maintained at 37 °C in a humidified atmosphere of 5% CO2. In order to mimic/induce steatosis, cells were incubated with 25 mM glucose, 10 nM insulin and 240 µM FFA (i.e. Palmitic acid and Oleic acid mixture 1:1) in serum-free culture medium in the presence or absence of sodium nitrite (10 µM) during 24, 48 or 72 hours. In the experiments with the pharmacological inhibitors, cells were pre-incubated with Febuxostat (50 nM), Raloxifene (50 nM), ODQ (10 µM) or Compound C (20 µM) 30 min prior to the 24 h treatment. Tempol (100 µM), NOX2/4 inhibitor (GLX481304, 1-50 µM). GLX7013114, 0.2-2 µM), the slow releasing NO-donor DETA-NONOate (5 µM) or cGMP analogue 8-pCPT-cGMP (10 µM) were administrated simultaneously with the steatosis-inducing media. Cell viability were assessed by Tryphan Blue exclusion assay and PrestoBlue® cell viability assay.
Primary human hepatocyte spheroids (Part III)
A 3D model using primary human hepatocyte (PHH) spheroid microtissues was used, as described previously (10) . In short, cryopreserved PHH (obtained from Bioreclamation IVT, USA) were used for formation of spheroid cultures. Cells were thawed according to supplier's instructions and seeded into ultra-low attachment 96-well plates (Corning) at 1,500 viable cells per well. Cells were seeded in 100 μl Williams E medium supplemented with 2 mM L-glutamine, 100 units/ml penicillin, 100 μg/ml streptomycin, 5.5 μg/ml transferrin, 6.7 ng/ml sodium selenite, 100 nM dexamethasone, and 10% FBS. The cell medium was also supplemented with physiological levels of glucose and insulin (final concentration 5.5 mM and 0.1 nM respectively) unless otherwise stated. Drug-induced steatosis, using Amiodarone, was studied in standard Williams E medium with final concentration of glucose and insulin of 11 mM and 1720 nM respectively as previously described by Bell et al. (10) . Spontaneous self-aggregation of the hepatocytes initiated spheroid formation. From day 5 after seeding, when the spheroids were sufficiently compact, 50% of the medium was exchanged daily for serum-free medium and spheroids were thereafter maintained in serum-free medium.
Induction of steatosis began at day 7 after seeding and spheroids were thereafter exposed to fresh cell media every 48-72 hours. Hepatic steatosis was induced with a combination of palmitic and oleic acid (molar ratio 1:1) (Sigma -Aldrich). The free fatty acids were initially bound to bovine serum albumin (Sigma-Aldrich) at a molar ratio of 1:5 at 40 °C for two hours in order to facilitate hepatic uptake.
Cell viability was assessed by determining the ATP content of single PHH spheroids with the CellTiter-Glo Luminescent Cell Viability Assay (Promega, Sweden). Luminescence signal was measured using MicroBeta LumiJET 2460 Microplate Counter (Perkin Elmer, USA). At the same time-points, cell culture medium was collected and albumin concentrations were determined by ELISA (Bethyl laboratories, USA). No significant differences in ATP production were found among groups.
The AdipoRed Adipogenesis Assay Reagent (Lonza, Switzerland) specifically partitions into fat droplets. Here it was used to measure lipid accumulation according to manufacturer's instructions. Briefly, AdipoRed Assay Reagent was added to single spheroids. Spheroids were disrupted by vigorous pipetting and fluorescence was thereafter measured (ex: 485, em: 572) in a whole-plate fluorometer (Spectra Max Gemini, Göteborgs Termometerfabrik, Sweden). In each experiment 4-10 spheroids were analyzed in two independent experiments. Preliminary studies using PHH from a different donor gave inconsistent results and were therefore not continued.
Cellular, molecular and biochemical analyses
NOX activity: Nicotinamide adenine dinucleotide phosphate (NADPH) oxidasemediated superoxide formation was detected by a lucigenin-dependent chemiluminescence assay, as described previously (4, 5) . In brief, tissues were separately homogenized in ice cold PBS and centrifuged at 4 °C for 20 min at 2000g. 100 μmol/L NADPH and 5 μmol/L lucigenin (Sigma-Aldrich) were added into the supernatant and the chemiluminescence signal was detected for 3 min using an AutoLumat LB953 Multi-Tube Luminometer (Berthold Technologies, Bad Wildbad, Germany). Results were corrected by protein quantification using Bradford protein assay (Bio-Rad Laboratories, Sundbyberg, Sweden).
After the treatments, HepG2 cells were washed with PBS and scraped to detach from the culture dish. Cell suspensions were transferred to measurement tubes and incubated with dark-adapted lucigenin (5 μmol/L) at 37 °C for 10 min. Superoxide production was started by the injection of the substrate NADPH (100 μmol/L) and the chemiluminescence signal was measured every 3 seconds for 3 min. Amplex Redderived fluorescence was used in order to measure NOX-derived superoxide and hydrogen peroxide generation in the mice´s liver. Liver pieces were separately homogenized in PBS with the bullet blender and zirconium oxide beads (0.5 mm). The fluorescence was measured for 120 min in a fluorescence microplate reader using excitation at 530 nm and fluorescence detection at 590 nm. The signal was normalized according to the protein concentration and presented as % changes of the respective control animals.
The NADPH-derived reactive oxygen species detected by lucigeninchemiluminescence technique in HepG2 cells was affirmed using experiments with superoxide dismutase (SOD) and incubation with catalase ( Figure S6 ). The latter did not influence the signal whereas SOD almost completely abolished it, thus demonstrating that this assay is predominantly assessing superoxide generation and not hydrogen peroxide.
Detection of superoxide and NO species by Electron Paramagnetic Resonance (EPR)
All EPR spectrums were evaluated using a Bench-top ESR spectrometer from Freiberg Instruments -Magnettech MiniScope MS5000. Superoxide (O2
•-
) and NO were detected using 5,5-Dimethyl-1-Pyrroline-N-Oxide (DMPO) and Fe(II)-diethyldithiocarbamate colloid (DETC) as spin traps, respectively. For O 2
•-detection, HepG2 cells were subjected to treatments for 48h and then cold washed with PBS and concentrated by centrifugation at 1500 g for 10 min. Cell pellet was then suspended in lysis buffer (50 mM Tris, 0.1 mM EDTA, 0.1mM EGTA; pH 7.4) and membrane fractions were isolated at 29,000 g. Membrane fractions (20 µg) were added to assay buffer containing DETC (10 mM), protease inhibitors cocktail, DMPO (50 mM) and NADPH (1 mM) and incubated for 20 min at 37 °C. The buffers were Chelex-treated and the assay buffer contains DTPA 100 mM. EPR acquisition parameters for O2
•-were: microwave frequency 100 kHz, center field 337 mT, modulation amplitude 0.1 mT, sweep width 11 mT, sweep time: 100 s, microwave power: 10 mW; total number of scans: 3.
NO was detected using Fe(II)-diethyldithiocarbamate colloid as described before (11) . In brief, HepG2 cells were grown to 80-90% confluence and serum-deprived for 24h in 100 mm dishes. The cells were then incubated for 1 h with sodium nitrite (0.5 mM) in the presence of colloid solution of Fe(II)-diethyldithiocarbamate (prepared by mixing sodium DETC 4.5 mg + FeSO4.7H2O 2.8 mg, dissolved separately in each 10 mL degassed PBS). The final colloid solution is 500 µM Fe(DETC)2. At the end of the incubation period, the supernatant was aspirated and the cell scraped and transferred to Eppendorf tubes, spun at 21000 RPM for 60 seconds and the pellet was dissolved in 50 µL PBS to be collected in a capillary tube. Acquisition parameters for NO were: microwave frequency 100 kHz, center field 331 mT, modulation amplitude 0.6 mT, sweep width 14 mT, sweep time: 30 s, microwave power: 10 mW; total number of scans: 3; In a subset of experiments, sodium nitrite with a stable isotope 15 N instead 14 N was used to differentiate NO formation from endogenous nitrite and exogenous nitrite treatments, since NO generated from 15 N display a duplet signal instead of the characteristic triplet from native 14 N.
EPR detection of iron-nitrosylated-hb species (Hb-NO and DNICs).
Samples of venous blood or liver from mice with HFD treatment were placed in one-end-cut 1 ml syringes and frozen in liquid nitrogen. The EPR spectra were recorded at 77K using an X-band table-top spectrometer MS5000 (Magnettech, Berlin). The instrument parameters were 10 mW microwave power, 0.6 mT amplitude modulation, 100 kHz modulation frequency, 330 mT center field, 40 mT sweep width, 60 s sweep time and 4 scans. The blood Hb-NO levels were assessed by measurement of the first component of the Hb-NO triplet EPR feature (g-factor=2, 01; AN=1,7 mT); the liver DNICs levels were assessed by measurement of the EPR peak at g= 2.04 (see (12) and references therein). EPR data were expressed in arbitrary units.
Lipid accumulation: Neutral lipid accumulation in cells and liver by Oil Red O (ORO) staining: After treatment, HepG2 cells were fixed with 4% paraformaldehyde for 30 min, washed with PBS and stained with ORO solution (0.2 mg/mL) for 1 h. Later, HepG2 cells were washed with PBS to remove unincorporated dye and images were acquired with a microscope. Lipid accumulation was semi-quantified by adding isopropanol to extract the dye from cells and subsequently measuring absorbance at 520 nm. Frozen livers from mice were embedded in Tissue-Tek and 6 µm sections were cut with a cryostat following the method described by Mehlem et al. (13) . The liver sections were allowed to equilibrate at room temperature and then fixed with 1% paraformaldehyde. Absolute propylene glycol was added for 3 min. The sections were incubated with pre-warmed ORO for 10 min followed by incubation with 85% propylene glycol for 5 min and Mayer´s hematoxylin for 30 sec. Then, the sections were rinsed under running tap water and mounted with glycerin mounting medium to acquire images. Lipid accumulation from the images was quantified in a blinded fashion using ImageJ software (i.e. the person doing the analysis/quantification was not aware of the experimental groups/treatments). In brief, in each image the color threshold was adjusted to select only the red channel and then transformed to black & white. The color was inverted so the white color represented the red staining. Then, the integrated density of the white color was measured.
Triglyceride Assay Kit (Abcam, ab65336) was used to quantify liver triglyceride content according with manufactor's protocol. In the assay triglycerides are converted to free fatty acids and glycerol. The glycerol is then oxidized to generate a product which reacts with the probe to generate color (spectrophotometry at λ= 570 nm) and fluorescence (Ex/Em = 535/587 nm).
Real-time quantitative reverse transcription polymerase chain reaction: mRNA expression levels were determined by real-time PCR. Liver pieces were separately homogenized in the bullet blender in the presence of Trizol and zirconium oxide beads (0.5 mm). The RNA from the homogenate was isolated by and incubation with chloroform follow by RNeasy Mini Kit (Qiagen, Sollentuna, Sweden) according to the manufacturer's instructions. mRNA purity and concentration were assessed using the Nanodrop ND-1000 (Thermo Fisher Scientific). Equal amounts of RNA were reverse transcribed to cDNA with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Real-time PCR was performed in 96-well plates in a total reaction volume of 20 μl on an ABI 7500 Real-Time PCR System using Power SYBR Green Master mix (Thermo Fisher Scientific) and gene specific primers. Mean x-fold relative gene expression changes were calculated with the ΔΔCt-method standardizing the results to the housekeeping gene β-actin. Primer sequences are described in Table  S2 .
In primary human hepatocyte spheroids, total RNA was isolated using Qiazol lysis reagent (Qiagen), and RNA was reverse-transcribed into cDNA using SuperScript III reverse transcriptase and RT-qPCR analysis was performed using a TaqMan Universal mix on a 7500 Fast Real-Time PCR system.
Western blot: Whole HepG2 cells were lysated in lysis buffer (10 mmol/L Tris-HCl pH 8, 150 mmol/L NaCl, 5 mmol/L EDTA, 60 mmol/L N-octyl-glucoside, 1 % Triton X-100, protease inhibitor cocktail and Serine/Threonine Protein Phosphatases or Tyrosine Protein Phosphatases inhibitors). Liver pieces were separately homogenized in the bullet blender in the presence of lysis buffer and zirconium oxide beads (0.5 mm). The supernatants and homogenates were collected and assayed for protein concentration by Bradford protein assay. Equal amounts of proteins were separated by 4-20 % SDS-polyacrylamide gels electrophoresis and transferred to polyvinylidene difluoride membranes. Blots were developed using Clarity Western ECL Substrate (Bio-Rad) and intensities were quantified using densitometry. Western Blot Strip-ping Buffer was applied followed by blocking and re-probing the membranes with primary antibody when needed. Vinculin was used as loading control. The antibodies used are in Table S3 . Uncropped gels with all western blots used in this study is shown in Figure S10 (Liver) and Figure S11 (HepG2 cells). Proteome analysis, as described in detail previously (10) , was used to obtain data on XOR expression in human liver samples, and in two-dimensional PHH (PHH 2D) as well as three-dimensional PHH (PHH 3D) that were cultured for 7 days. Briefly, cell and liver samples were subjected to one freeze-thaw cycle, sonicated and centrifuged. 100μg protein/sample were denatured, reduced and treated with methyl methanethiosulfonate according to the manufacturer's protocol (Sciex, Framingham, MA, USA), before being labelled with isobaric tags for absolute and relative quantification (iTRAQ), pre-fractionated by cation exchange chromatography and analysed on a Triple TOF 5600 (Sciex).
Chemicals: sodium nitrate (NaNO3, Sigma), sodium nitrite (NaNO2, Sigma), Nω-nitro-L-arginine methyl-ester hydrochloride (L-NAME, Sigma), Febuxostat (Selleckchem), DETA-NONOate Statistics: Data are presented as the mean ± SEM unless otherwise indicated. Statistical analysis was performed by using one-way, two-way ANOVA or nonparametric Kruskal Wallis test, followed by posthoc test for comparisons among the groups. A P value of less than 0.05 was considered statistically significant. All statistical analysis was performed using GraphPad Prism, version 7 (GraphPad Software). The mRNA expression of XOR in livers from mice with HFD treatment+L-NAME, with or without nitrate supplementation (A). Protein expression in human livers samples and in corresponding two-dimensional primary human hepatocytes (2D PHH) and three-dimensional PHH (3D PHH) cultured for 7 days in control medium (B). Data are presented as the mean ± SEM. n=9-10 (A), n=4 (B) and n=4 (C) per group. *, **, *** denotes p<0.05, p<0.01, and p<0.001 respectively, between indicated groups, tested by Kruskal-Wallis test and Dunn's test. HFD, high fat diet+L-NAME. 
